ArticleQRB discovery2020

Biovacc-19: A Candidate Vaccine for Covid-19 (SARS-CoV-2) Developed from Analysis of its General Method of Action for Infectivity.

Birger Sørensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.